ArticleScientific reports2025
AI-driven analysis by identifying risk factors of VL relapse in HIV co-infected patients.
Article in Scientific reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Prognostic models predicting clinical outcomes in patients diagnosed with visceral leishmaniasis: a systematic review.BMJ public health · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
Abstract
Visceral Leishmaniasis (VL), also known as Kala-Azar, poses a significant global public health challenge and is a neglected disease, with relapses and treatment failures leading to increased morbidity and mortality. This study introduces an explainable machine learning approach to predict VL relapse and identify critical risk factors, thereby aiding patient monitoring and treatment strategies. Leveraging data from a follow-up study of 571 patients, the survival machine learning models are applied, including Random Survival Forest (RSF), Survival Support Vector Machine (SSVM), and eXtreme Gradient Boosting (XGBoost), for relapse prediction. The results demonstrated that RSF, with a C-index of 0.85, outperformed the conventional Cox Proportional Hazard (CPH) model (C-index 0.8), offering improved prediction capabilities by capturing non-linear relationships and variable interactions. To address the lack of transparency (in terms of feature importance) in Machine Learning (ML) models, the SHapley Additive exPlanation (SHAP) method is employed, which enhances model interpretability (feature importance) through visual insights. SHAP dependence plots allowed the healthcare professionals to evaluate which factors encourage the occurrence of the relapse. A statistically significant relationship between HIV co-infection (HR=3.92, 95% CI=2.03-7.58) and VL relapse was identified through -2 log-likelihood ratio and chi-square tests. These results indicate the promise of explainable artificial intelligence (XAI) for making clinical decisions and remedying recurrences in VL.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.